Folfirinox + Cetuximab Chemotherapy, in First Line, With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer
Clinical trial NCT03914170 · COMPLETED
Trial details
- NCT number
- NCT03914170
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-01
- Primary completion
- 2018-04-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.